![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, February 23, 2020 5:39:03 PM
Fortunately, just the opposite should be true for psoriasis in the case of a topical cream for it. In a matter or days or weeks improvement should be clear. The FDA may want a number of months to prove it's durable, but it won't take years, to even decades as some oncology products due. Then it should be possible to permit the earnings from the psoriasis cream to fund the MM trial, at least in part. A substantially higher stock price could certainly fund it with some dilutive funding as well. Investors may not like dilution, but when the share price reaches high single digit to low double digit dollars, I don't believe investors will mind.
I believe there is other good news on many of the products the company is working on. Once patent approvals come it, the trial process for the conditions they're directed at may be longer than psoriasis, but it's nowhere near as long, or expensive as going after MM or other cancers.
I suspect that once more is known about patent, and trials of the cream, the likelihood of a BP partnering with OWCP will be far greater, and that too will greatly take care of funding for the companies many products.
Gary
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM